Cardiovascular involvement in systemic rheumatic diseases: An integrated view for the treating physicians

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Systemic autoimmune diseases frequently impact multiple organs, including the cardiovascular system.
• Cardiovascular involvement in rheumatic diseases encompasses myocardium, pericardium, vessels, conduction, and valves, contributing to increased mortality.
• Chronic inflammation in rheumatic diseases accelerates atherosclerosis and can lead to silent heart failure and arrhythmias.

Purpose of the Study:

• To review the current evidence on cardiovascular involvement in rheumatic diseases.
• To highlight the importance of early diagnosis and management of cardiovascular risk factors.
• To discuss the role of immunosuppressive agents in cardiovascular health within rheumatic disease patients.

Main Methods:

• Literature review focusing on cardiovascular manifestations in rheumatic diseases.
• Analysis of disease-specific factors influencing cardiovascular health.
• Discussion of traditional cardiovascular risk factors and their management.
• Brief overview of immunosuppressive drug cardiotoxicity.

Main Results:

• Disease-specific factors (duration, severity, activity, antibodies) significantly impact cardiovascular health.
• Traditional risk factors like hypercholesterolemia and hypertension require intensive management.
• Immunosuppressive agents control rheumatic diseases, but their direct cardioprotective effects require further definition.
• Cardiotoxicity from immunosuppressive drugs is rare but noted.

Conclusions:

• Cardiovascular involvement is a critical, often silent, complication of rheumatic diseases.
• Integrated management addressing both disease activity and cardiovascular risk factors is essential.
• Further research is needed to clarify the cardioprotective role of immunosuppressive therapies.